This week at Retraction Watch featured revelations about legal threats to PubPeer, and a swift expression of concern for a paper denying the link between HIV and AIDS. Here’s what was happening elsewhere: Continue reading Weekend reads: A journal that will publish anything, even fake; Wakefield loses defamation suit appeal
Publisher issues statement of concern about HIV denial paper, launches investigation
The publisher Frontiers has issued a Statement of Concern about a paper denying that HIV causes AIDS, and has launched an investigation into how the paper was published in the first place.
The paper, “Questioning the HIV-AIDS hypothesis: 30 years of dissent,” is written by Patricia Goodson of Texas A&M University and was published on September 23 in Frontiers in Public Health. As Tara Smith, who blogged about the paper yesterday, notes: Continue reading Publisher issues statement of concern about HIV denial paper, launches investigation
Notice fails to get to the heart of cardiology retraction
A cardiology paper from China has been retracted because “permission to report these discussions was not sought nor obtained,” though it’s unclear what “the discussions” refers to. The person to whom the discussions are attributed to in the retraction, Ji Bingyang, is not an author on the paper, and none of his papers are cited in the retracted article.
Here’s the notice in the Chinese Medical Journal for “A novel rat model of cardiopulmonary bypass for deep hypothermic circulatory arrest without blood priming”:
Continue reading Notice fails to get to the heart of cardiology retraction
Deceased researcher has two more papers retracted
A late researcher in Italy who has already been blamed for image manipulation in a PLOS ONE retraction notice has had two more papers retracted, both from Free Radical Biology and Medicine.
Here’s the notice for 2007’s “Redox regulation of 7-ketocholesterol-induced apoptosis by β-carotene in human macrophages,” by Paola Palozza and colleagues: Continue reading Deceased researcher has two more papers retracted
Downstream effects: Comment on retracted narcolepsy paper retracted
The recent retraction of a paper in Science Translational Medicine reporting “one of the biggest things to happen” in narcolepsy research has claimed a bystander: A letter that commented on the no-longer-landmark article.
The authors of the letter are with GlaxoSmithKline’s vaccine division. Here’s the new notice: Continue reading Downstream effects: Comment on retracted narcolepsy paper retracted
Data questions prompt retraction of PLOS ONE cardiovascular paper
PLoS One has retracted a 2013 article on atherosclerosis in mice over concerns about the integrity of the data.
The paper, “The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice,” came from a group of researchers in South Korea.
It purported to show that: Continue reading Data questions prompt retraction of PLOS ONE cardiovascular paper
“Wide differences in the memories” prompt expression of concern for Poldermans paper
The European Heart Journal has issued an expression of concern for a 2014 2001 paper by Don Poldermans, the Dutch heart researcher who stepped down from his post at Erasmus University after being accused of misconduct.
The article, “Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery,” appeared in July and reported data from the DECREASE trial. Poldermans, who left Erasmus in 2011, has acknowledged failing to receive informed consent from some patients in one phase of the DECREASE study but denied having fabricated results.
According to the notice: Continue reading “Wide differences in the memories” prompt expression of concern for Poldermans paper
Retraction, tell-all style, for breast cancer radiology paper
Here at Retraction Watch, we don’t believe in the expression “TMI.” But this case features a level of detail we’re not sure we’ve seen before.
Acta Radiologica has pulled a 2012 article on breast cancer imaging for being a duplicate publication — a sin the retraction notice takes great pains to point out.
The notice, written by journal editor Arnulf Skjennald, has the blow-by-blow feel of a police report: Continue reading Retraction, tell-all style, for breast cancer radiology paper
PubPeer Selections: Was a Nature correction adequate?; Use of samples from patients with COPD questioned
Here’s another installment of PubPeer Selections: Continue reading PubPeer Selections: Was a Nature correction adequate?; Use of samples from patients with COPD questioned
Hepatology issues corrections in two papers from Pitt liver group
A group of liver researchers from the University of Pittsburgh has earned a pair of corrections in Hepatology for image problems.
The team was led by George K. Michalopoulos, chair of the department of pathology at the University of Pittsburgh Medical Center.
One article, “Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene,” appeared in January 2011. According to the notice: Continue reading Hepatology issues corrections in two papers from Pitt liver group
